Table 2.

Details of grafting materials and techniques used in the 12 studied reviews

Type of graft	Lead author	Year	Graft material	Incision	Grafting suture material	NVB dissection	Graft size	Additional grafts	Concurrent convex, % (n/N)
Xenograft	Sayedahmed19	2017	SIS	YY (Egydio)	NM	NM	>20% larger than defect	NM	NM
	Cosentino20	2016	SIS	H	4-0 Vicryl	NM	6.5 cm2; >0.5 cm larger than defect	NM	NM
	Knoll21	2007	SIS∗	H	4-0 polyglycolic acid	NM	30% larger than defect	NM	NM
	Sansalone22	2011	BPCM	YY (Egydio)	4-0 poliglecaprone	NM	NM	NM	NM
Allograft	Sampaio23	2002	HDM	I	NM	NM	0.5 cm wider, 1 cm longer than defect	NM	NM
Autograft	Kadioglu24	2018	SV	H/YY (Egydio)	5-0 PDS	Medial	NM	NM	33.3 (48/144)
	Kalsi25	2005	SV	H/I	3-0 polypropylene/3-0 PDS	Lateral/medial†	NM	(30/113 2x)/(5/113 3x)	38.1 (43/113)
	Montorsi26	2000	SV	H	5-0 PDS	XXX	NM	(44/50 2x)/(1/50 3x)	12.0 (6/50)
	Akkus27	2001	SV/DDV	H/I	4-0 Vicryl/5-0 Vicryl	NM	NM	NM	24.1 (14/58)
	El Sakka13	1998	SV	H	NM	NM	NM	12% >1x	33.0 (37/112)
Multiple	Flores15	2011	CP (52)/SIS (4)	H/YY (Egydio)	4-0 PDS	NM	8 cm2 (SD ±6; range, 4–28)	NM	0.0 (0/56)
	Chung28	2011	D (22)/CP (33)/SIS (33)	NM	NM	NM	20% larger than defect	NM	NM

BPCM = bovine pericardium collagen matrix; CP = cadaveric pericardium; D = dermal; DDV = deep dorsal vein; HDM = human dura mater; NM = not mentioned; PDS = polydioxanone; SD = standard deviation; SIS = small intestinal submucosa; SV = saphenous vein.

^∗Histological report available.

^†Medially in patients with ED or arterial risk factors.